Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway

被引:2
|
作者
Nakanishi, T
Hayashi, A
Kunisawa, J
Tsutsumi, Y
Tanaka, K
Yashiro-Ohtani, Y
Nakanishi, M
Fujiwara, H
Hamaoka, T
Mayumi, T
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Toxicol, Osaka, Japan
[3] Osaka Univ, Sch Med, Biomed Res Ctr, Osaka 553, Japan
[4] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
关键词
cytotoxic T lymphocyte; MHC class I; fusogenic liposome; vaccine; ovalbumin;
D O I
10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exogenous soluble proteins enter the endosomal pathway by endocytosis and are presented in association with MHC class II rather than class I. In contrast, the delivery of exogenous protein antigens (Ag) into the cytosol generates MHC class I-restricted cytotoxic T lymphocytes (CTL) responses. Although several immunization approaches, such as the utilization of liposomes, have induced the in vivo priming of MHC class I-restricted CTL responses to protein Ag, it remains unclear whether this priming results from the direct delivery of protein Ag to the cytosol. Here we report that fusogenic liposomes (FL), which are prepared by fusing simple liposomes with Sendai virus particles, can deliver the encapsulated soluble protein directly into the cytosol of cells cultured concurrently and introduce it into the conventional MHC class I Ag presentation pathway. Moreover, a single immunization with ovalbumin (OVA) encapsulated in FL but not in simple liposomes results in the potent priming of OVA-specific CTL. Thus, FL function as an efficient tool for the delivery of CTL vaccines.
引用
收藏
页码:1740 / 1747
页数:8
相关论文
共 50 条
  • [21] Presentation of exogenous antigen in MHC class I-restricted manner
    Yamazaki, H
    Fujimaki, H
    Tanaka, M
    Tanaka, K
    Minami, M
    FASEB JOURNAL, 1996, 10 (06): : 2823 - 2823
  • [22] PROCESSING OF EXOGENOUS PARTICULATE ANTIGEN FOR PRESENTATION BY MHC-I MOLECULES
    HARDING, CV
    FASEB JOURNAL, 1994, 8 (05): : A748 - A748
  • [23] Polymorphisms in MHC class I molecules influence their interactions with components of the antigen processing and presentation pathway
    Aflalo, Aure
    Boyle, Louise H.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2021, 48 (04) : 317 - 325
  • [24] Delivery by Trypanosoma cruzi of proteins into MHC class I antigen processing and presentation pathway.
    Garg, N
    Nunes, M
    Tarleton, RL
    FASEB JOURNAL, 1996, 10 (06): : 110 - 110
  • [25] Nitrosylation of platelet MHC class I molecules directs their movement into the immumosuppressive MHC class I processing pathway within antigen presenting cells.
    Semple, JW
    Speck, ER
    Freedman, J
    BLOOD, 2004, 104 (11) : 239A - 239A
  • [26] New tools for antigen delivery to the MHC class I pathway
    Morón, G
    Dadaglio, G
    Leclerc, C
    TRENDS IN IMMUNOLOGY, 2004, 25 (02) : 92 - 97
  • [27] Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway
    Tey, Siok-Keen
    Khanna, Rajiv
    BLOOD, 2012, 120 (05) : 994 - 1004
  • [28] Expression, purification and characterization of ricin vectors used for exogenous antigen delivery into the MHC class I presentation pathway
    Daniel C. Smith
    Catherine J. Marsden
    J. Michael Lord
    Lynne M. Roberts
    Biological Procedures Online, 2003, 5 (1) : 13 - 19
  • [29] The function of the proteasome system in MHC class I antigen processing
    Stoltze, L
    Nussbaum, AK
    Sijts, A
    Emmerich, NPN
    Kloetzel, PM
    Schild, H
    IMMUNOLOGY TODAY, 2000, 21 (07): : 317 - 319
  • [30] The regulation of proteasomal MHC class I antigen processing activity
    Groettrup, M
    Soza, A
    Schmidtke, G
    Kuckelkorn, U
    Theobald, M
    Eggers, M
    Ruppert, T
    Koszinowski, U
    Kloetzel, PM
    CANCER GENE THERAPY, 1997, 4 (05) : 308 - 309